RPS15P9

Across TCGA pan-cancer cohorts, RPS15P9 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPS15P9’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS15P9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS15P9 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

COAD, PAAD, and KIRC are the cancer types where RPS15P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS15P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.269	<.001	6	view →
PAAD	All	All	−0.422	.007	2	view →
KIRC	All	All	+0.057	.006	2	view →
LIHC	All	All	+0.043	.005	2	view →
LUSC	All	All	+0.095	.032	1	view →
HNSC	All	II,III,IV	+0.067	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RPS15P9–COAD

Open the COAD breakdown →